Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05240794 · ClinicalTrials.gov registry record · NA

Effects of Therapeutic Mobile Game on Anxiety

A NA study of Social Anxiety Disorder, sponsored by Hunter College of City University of New York.

Completed
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT05240794 is a NA study of Social Anxiety Disorder that has completed, run by Hunter College of City University of New York. The registered enrollment target is 150 participants, roughly in line with the 155-participant average among 32 other Social Anxiety Disorder trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05240794, a NA study of Social Anxiety Disorder, has completed, sponsored by Hunter College of City University of New York.

COMPLETED
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

Participants with Social Anxiety Disorder (SAD) will use a digital therapeutic for 30 days, and will complete assessments measuring a broad range of anxiety and mood-related symptoms, with a focus on SAD symptoms, and metrics of functional impairment during this time. After the treatment period, participants will be followed at 6 month and 12 month after the completion of the study.

Conditions Studied

Interventions

  • DEVICE ABM-01
  • DEVICE Digital Control

Study Locations (1)

New York

  • Hunter College of the City University of New York - New York

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2022-06-15
Est. Completion 2023-05-31
Phase NA

What the Registry Record Tells You About NCT05240794

The ClinicalTrials.gov registry entry for NCT05240794 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 155-participant average among 32 other Social Anxiety Disorder trials with a reported enrollment target. The listed sponsor is Hunter College of City University of New York, which has 29 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Social Anxiety Disorder appearing as the primary indexed condition, and to 2 interventions - of which ABM-01 is the first listed.

NCT05240794 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05240794 about?

NCT05240794 is a clinical study titled "Effects of Therapeutic Mobile Game on Anxiety". Participants with Social Anxiety Disorder (SAD) will use a digital therapeutic for 30 days, and will complete assessments measuring a broad range of anxiety and mood-related symptoms, with a focus on SAD symptoms, and metrics of functional impairment during this time. After the treatment period, par...

What is the current status of trial NCT05240794?

This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2022-06-15. Estimated completion is 2023-05-31.

What conditions does trial NCT05240794 study?

This clinical trial studies the following conditions: Social Anxiety Disorder.

What interventions are being tested in trial NCT05240794?

The interventions under investigation include: ABM-01 (DEVICE), Digital Control (DEVICE).

Who is sponsoring clinical trial NCT05240794?

This trial is sponsored by Hunter College of City University of New York, which has 29 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05240794 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Social Anxiety Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.